Advisory Services Network’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$2.37K 4038
2022
Q4
$2.37K Buy
+1,500
New +$2.02K ﹤0.01% 3383

Other funds holding DMAC

Advisory Services Network's DMAC Position: Q1 2023 in Review

Advisory Services Network sold out of DiaMedica Therapeutics (DMAC) in Q1 2023, closing a stake of 1,500 shares — an estimated $2.37K sold.

Advisory Services Network first reported a position in DMAC in Q4 2022 and held it in 1 quarter. The position peaked at $2.37K in Q4 2022. 25 funds tracked by Wall St. Rank hold DMAC as of Q1 2023.

  • Advisory Services Network reported no remaining DiaMedica Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Advisory Services Network sold 1,500 DiaMedica Therapeutics shares in Q1 2023, an estimated $2.37K.
  • Advisory Services Network first reported a position in DiaMedica Therapeutics in Q4 2022 and held it in 1 quarter.
  • Advisory Services Network's DiaMedica Therapeutics position peaked at $2.37K in Q4 2022.
  • 25 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2023.

Based on Advisory Services Network's 13F filing for Q1 2023, filed 17 May 2023.